npj Precision Oncology · 2024 · 15 citations · 32 references
MedicineMolecular BiologyOncologyInnate ImmunityMolecular OncologyTumor MicroenvironmentExtracellular Vesicle SignalingLung CancerMicrorna-mediated RegulationNoncoding Rna BiologyNoncoding Rna FunctionNoncoding Rna In CancerCancer-associated MacrophagesCancer-related Noncoding Rna FunctionExtracellular Vesicle ReleaseExtracellular Vesicle TraffickingLong Non-coding Rna BiomarkersLong Non-coding Rna FunctionMicrorna In CancerTumor-specific Biomarkers
Non-small cell lung cancer (NSCLC) constitutes the majority of lung cancer cases, accounting for over 80%. RNAs in EVs play a pivotal role in various biological and pathological processes mediated by extracellular vesicle (EV). Long non-coding RNAs (lncRNAs) are widely associated with cancer-related functions, including cell proliferation, migration, invasion, and drug resistance. Tumor-associated macrophages are recognized as pivotal contributors to tumorigenesis. Given these insights, this study aims to uncover the impact of lncRNA NORAD in EVs derived from M2 macrophages in NSCLC cell lines and xenograft mouse models of NSCLC. EVs were meticulously isolated and verified based on their morphology and specific biomarkers. The interaction between lncRNA NORAD and SMIM22 was investigated using immunoprecipitation. The influence of SMIM22/GALE or lncRNA NORAD in EVs on glycolysis was assessed in NSCLC cell lines. Additionally, we evaluated the effects of M2 macrophage-derived lncRNA NORAD in EVs on cell proliferation and apoptosis through colony formation and flow cytometry assays. Furthermore, the impact of M2 macrophage-derived lncRNA NORAD in EVs on tumor growth was confirmed using xenograft tumor animal models. The results underscored the potential role of M2 macrophage-derived lncRNA NORAD in EVs in NSCLC. SMIM22/GALE promoted glycolysis and the proliferation of NSCLC cells. Furthermore, lncRNA NORAD in EVs targeted SMIM22 and miR-520g-3p in NSCLC cells. Notably, lncRNA NORAD in EVs promoted the proliferation of NSCLC cells and facilitated NSCLC tumor growth through the miR-520g-3p axis. In conclusion, M2 macrophage-derived lncRNA NORAD in EVs promotes NSCLC progression through the miR-520g-3p/SMIM22/GALE axis.
32
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 21K citations · Full text
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang, Chenwei Li, Chenwei Li et al. · Nucleic Acids Research · 2017 · 10.6K citations · Full text
Characterization of extracellular circulating microRNA
Andrey Turchinovich, Ludmila Weiz, Anne Langheinz et al. · Nucleic Acids Research · 2011 · 1.9K citations · Full text
Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins
Sung‐Yul Lee, Florian Kopp, Tsung-Cheng Chang et al. · Cell · 2015 · 954 citations · Full text